CHO Pharma Statistics

Total Valuation

CHO Pharma has a market cap or net worth of TWD 7.98 billion. The enterprise value is 5.78 billion.

Market Cap	7.98B
Enterprise Value	5.78B

Important Dates

The last earnings date was Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

CHO Pharma has 214.01 million shares outstanding. The number of shares has increased by 11.86% in one year.

Current Share Class	214.01M
Shares Outstanding	214.01M
Shares Change (YoY)	+11.86%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	18.51%
Owned by Institutions (%)	17.00%
Float	143.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2,486.79
PB Ratio	3.03
P/TBV Ratio	3.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-25.08
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-23.26

Financial Position

The company has a current ratio of 21.85, with a Debt / Equity ratio of 0.01.

Current Ratio	21.85
Quick Ratio	21.33
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.09
Interest Coverage	-493.48

Financial Efficiency

Return on equity (ROE) is -8.37% and return on invested capital (ROIC) is -6.02%.

Return on Equity (ROE)	-8.37%
Return on Assets (ROA)	-5.82%
Return on Invested Capital (ROIC)	-6.02%
Return on Capital Employed (ROCE)	-10.16%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.09% in the last 52 weeks. The beta is -0.53, so CHO Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.53
52-Week Price Change	-39.09%
50-Day Moving Average	39.83
200-Day Moving Average	48.25
Relative Strength Index (RSI)	31.58
Average Volume (20 Days)	267,531

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CHO Pharma had revenue of TWD 3.21 million and -230.38 million in losses. Loss per share was -1.07.

Revenue	3.21M
Gross Profit	1.66M
Operating Income	-267.96M
Pretax Income	-230.38M
Net Income	-230.38M
EBITDA	-255.98M
EBIT	-267.96M
Loss Per Share	-1.07

Full Income Statement

Balance Sheet

The company has 2.23 billion in cash and 21.78 million in debt, giving a net cash position of 2.21 billion or 10.30 per share.

Cash & Cash Equivalents	2.23B
Total Debt	21.78M
Net Cash	2.21B
Net Cash Per Share	10.30
Equity (Book Value)	2.63B
Book Value Per Share	12.25
Working Capital	2.18B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -244.75 million and capital expenditures -3.62 million, giving a free cash flow of -248.37 million.

Operating Cash Flow	-244.75M
Capital Expenditures	-3.62M
Free Cash Flow	-248.37M
FCF Per Share	-1.16

Full Cash Flow Statement

Margins

Gross Margin	51.84%
Operating Margin	-8,347.66%
Pretax Margin	-7,176.79%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CHO Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.86%
Shareholder Yield	n/a
Earnings Yield	-2.89%
FCF Yield	-3.11%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a